ArticleJournal of neuroendovascular therapy2026
Single-Phase CTA Guided by the Time-Enhancement Curve Derived from CT Perfusion for Mechanical Thrombectomy.
Article in Journal of neuroendovascular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Mechanical thrombectomy (MT) is currently the standard treatment for large vessel occlusion (LVO). However, advancing a microcatheter and microguidewire into non-visualized distal vessels carries a risk of vascular perforation, potentially resulting in serious hemorrhagic complications. This study aimed to evaluate the usefulness of a new imaging protocol using single-phase CTA guided by the time-enhancement curve (TEC) derived from CT perfusion (CTP) in patients with anterior circulation LVO undergoing MT, for improving distal vessel visualization compared with conventional CTA using a bolus-tracking (BT) method. Methods: Patients with anterior circulation LVO (intracranial internal carotid artery, M1 or proximal M2 segment of the middle cerebral artery) who underwent MT were retrospectively analyzed. The conventional BT-CTA protocol was used between October 2018 and June 2020, and a new CTP-derived TEC-guided CTA (TEC-CTA) protocol was used between July 2020 and August 2023. In the TEC-CTA protocol group, the scan timing of CTA was determined according to the TEC obtained from CTP to achieve optimal contrast filling of distal vessels. Visualization of vessels distal to the occlusion site was graded on a 4-point scale (0-3) and compared between the 2 protocols. Scores of 2 and 3 were considered useful for predicting the extent of thrombus and the vessel course. Additional outcomes included the puncture-to-recanalization time (PRT), thrombolysis in cerebral infarction (TICI) grade, complications, and modified Rankin Scale (mRS) score at 90 days. Results: Sixteen and 46 patients underwent MT using the BT-CTA and TEC-CTA protocols, respectively. The incidence of well-visualized vessels overall (score of 2 or 3) was significantly higher in the TEC-CTA protocol group than in the BT-CTA protocol group (80.4% vs. 37.5%; p = 0.0033). The PRT was significantly shorter in the TEC-CTA protocol group than in the BT-CTA protocol group (44 vs. 58 min; p = 0.0134). The proportion of patients with TICI ≥2b after revascularization appeared to be higher using the TEC-CTA protocol (82.6% vs. 75.0%), but this was not significant. No intraprocedural vascular perforation occurred in either protocol, and no significant difference was observed in the frequency of intracranial hemorrhage between the protocols. The proportion of patients whose mRS score was ≤3 at 90 days after stroke onset was significantly higher in the TEC-CTA protocol group than in the BT-CTA protocol group (56.5% vs. 25%; p = 0.0424). Conclusion: CTA performed with scan timing guided by CTP-derived TEC improves visualization of occluded vessels, contributing to safer and more effective MT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.